nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adenovirus-mediated expression of myogenic differentiation factor 1 (MyoD) in equine and human dermal fibroblasts enables their conversion to caffeine-sensitive myotubes
|
Fernandez-Fuente, Marta |
|
2014 |
24 |
3 |
p. 250-258 9 p. |
artikel |
2 |
Adult polyglucosan body disease in a patient originally diagnosed with Fabry’s disease
|
Sagnelli, A. |
|
2014 |
24 |
3 |
p. 272-276 5 p. |
artikel |
3 |
A new disease allele for the p.C30071R mutation in titin causing hereditary myopathy with early respiratory failure
|
Pfeffer, Gerald |
|
2014 |
24 |
3 |
p. 241-244 4 p. |
artikel |
4 |
Early infantile sensory-motor neuropathy with late onset respiratory distress
|
Blaschek, Astrid |
|
2014 |
24 |
3 |
p. 269-271 3 p. |
artikel |
5 |
Editorial Board
|
|
|
2014 |
24 |
3 |
p. IFC- 1 p. |
artikel |
6 |
Excessive risk of cancer and in particular lymphoid malignancy in myasthenia gravis patients: A population-based cohort study
|
Yeh, Jiann-Horng |
|
2014 |
24 |
3 |
p. 245-249 5 p. |
artikel |
7 |
Factors of importance for dynamic balance impairment and frequency of falls in individuals with myotonic dystrophy type 1 – A cross-sectional study – Including reference values of Timed Up & Go, 10m walk and step test
|
Hammarén, Elisabet |
|
2014 |
24 |
3 |
p. 207-215 9 p. |
artikel |
8 |
Late-onset spinal motor neuronopathy – A common form of dominant SMA
|
Penttilä, Sini |
|
2014 |
24 |
3 |
p. 259-268 10 p. |
artikel |
9 |
Monoclonal antibodies for clinical trials of Duchenne muscular dystrophy therapy
|
Lam, Le Thanh |
|
2014 |
24 |
3 |
p. 195-200 6 p. |
artikel |
10 |
Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies
|
Bachinski, Linda L. |
|
2014 |
24 |
3 |
p. 227-240 14 p. |
artikel |
11 |
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy
|
Pane, Marika |
|
2014 |
24 |
3 |
p. 201-206 6 p. |
artikel |
12 |
Reliability of the walking energy cost test and the six-minute walk test in boys with Duchenne muscular dystrophy
|
Kempen, J.C.E. |
|
2014 |
24 |
3 |
p. 216-221 6 p. |
artikel |
13 |
6th Dysferlin Conference, 3–6 April 2013, Arlington, Virginia, USA
|
Albrecht, Douglas E. |
|
2014 |
24 |
3 |
p. 277-287 11 p. |
artikel |
14 |
The 2-min walk test is sufficient for evaluating walking abilities in sporadic inclusion body myositis
|
Alfano, L.N. |
|
2014 |
24 |
3 |
p. 222-226 5 p. |
artikel |